6.40p-0.62 (-8.83%)24 Apr 2024, 16:30
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.AJ Bell logo

Synairgen PLC Market & Company News

03.03.2022 20:34PCA, SVML, EGYTRADING UPDATES: Next Fifteen raises GBP50 million; N Brown sales upAlliance
03.03.2022 11:29DOTD, SNGAIM WINNERS & LOSERS: dotDigital plunges after profit warningAlliance
03.03.2022 07:00SNGUpdate on SNG001RNS
24.02.2022 11:30SNGHolding(s) in CompanyRNS
23.02.2022 11:25SNGHolding(s) in CompanyRNS
21.02.2022 12:25SNGSynairgen falls as trial for Covid treatment fails to meet endpointsAlliance
21.02.2022 11:33AFN, SNG, BVXAIM WINNERS & LOSERS: Morses Club sinks on profit warning, CEO exitAlliance
21.02.2022 07:00SNGTopline results from Phase 3 SPRINTER trialRNS
04.02.2022 16:54SNGHolding(s) in CompanyRNS
28.01.2022 07:00SNGDirector/PDMR ShareholdingRNS
19.01.2022 14:05SNGHolding(s) in CompanyRNS
12.01.2022 11:53SNGHolding(s) in CompanyRNS
07.01.2022 17:25SNGHolding(s) in CompanyRNS
06.01.2022 12:00SNGSynairgen announces partnership with AshfieldReach
23.12.2021 16:15SNGHolding(s) in CompanyRNS
23.12.2021 14:19SNGHolding(s) in CompanyRNS
21.12.2021 17:05SNGHolding(s) in CompanyRNS
08.12.2021 07:00SNGData Presented at ESWI Influenza ConferenceRNS
06.12.2021 17:30SNGHolding(s) in CompanyRNS
06.12.2021 07:00SNGSynairgen Presents SNG001 Data at ESWIRNS
19.11.2021 14:26SNGHolding(s) in CompanyRNS
11.11.2021 07:00SNGSynairgen completes Phase III recruitmentRNS
08.11.2021 12:58SNGHolding(s) in CompanyRNS
26.10.2021 15:13SNGHolding(s) in CompanyRNS
21.10.2021 17:39SNGHoldings in CompanyRNS
21.10.2021 07:00SNGGrant of OptionsRNS
20.10.2021 07:00SNGSNG001 progresses to Phase 3 of ACTIV-2 trialRNS
13.10.2021 07:00SNGSynairgen appoints Gareth Walters, Ph.D. as CROReach
05.10.2021 11:25SNGHolding(s) in CompanyRNS
30.09.2021 07:02SNGNon-Executive Director AppointmentRNS
30.09.2021 07:00SNGInterim resultsRNS
21.09.2021 07:00SNGSynairgen Notice of Interim ResultsRNS
10.09.2021 11:30SNGHolding(s) in CompanyRNS
12.08.2021 16:12SNGExercise of Options and Total Voting RightsRNS
06.08.2021 12:21SNGHolding(s) in CompanyRNS
29.06.2021 16:28SNGHolding(s) in CompanyRNS
18.06.2021 10:29SNGResult of AGMRNS
07.06.2021 07:00SNGGrant of OptionsRNS
25.05.2021 16:28SNGNotice of AGMRNS
24.05.2021 07:00SNGResults of in vitro studiesReach
12.05.2021 07:00SNGFull Year ResultsRNS
30.04.2021 07:00SNGHome Cohort data of SG016 Phase II trialRNS
16.04.2021 16:37SNGHolding(s) in CompanyRNS
15.04.2021 11:44SNGHolding(s) in CompanyRNS
06.04.2021 16:36SNGHolding(s) in CompanyRNS
15.02.2021 07:00SNGDosing commenced in US ACTIV-2 trialRNS
25.01.2021 07:00SNGInclusion in US ACTIV-2 trialRNS
20.01.2021 07:00SNGHome trial recruitment completedRNS
13.01.2021 07:00SNGFirst Patient Dosing in Phase III SG018 TrialRNS
06.01.2021 17:10SNGHolding(s) in CompanyRNS
05.01.2021 17:53SNGHolding(s) in CompanyRNS
Showing 76 to 126 of 126